Taiwanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.0b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Lotus Pharmaceutical

Market Cap: NT$61.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Maxigen Biotech

Market Cap: NT$3.7b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

HeXun Biosciences

Market Cap: NT$2.9b

Engages in the research and development of stem cell and treatments in Taiwan.

PharmaEngine

Market Cap: NT$9.7b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

PharmaEssentia

Market Cap: NT$191.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Anxo Pharmaceutical

Market Cap: NT$1.3b

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

Syngen BiotechLtd

Market Cap: NT$3.4b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

YungShin Global Holding

Market Cap: NT$15.1b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

Cenra

Market Cap: NT$6.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Bioray Biotech

Market Cap: NT$710.0m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

Formosa Laboratories

Market Cap: NT$7.8b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Welgene BiotechLtd

Market Cap: NT$522.0m

Provides genetic testing services.

Nang Kuang Pharmaceutical

Market Cap: NT$3.8b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

BioLASCO Taiwan

Market Cap: NT$847.8m

Provides bio-materials and surgical services in Taiwan and internationally.

Synmosa Biopharma

Market Cap: NT$15.8b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

Bora Pharmaceuticals

Market Cap: NT$84.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan and Asia.

Winston Medical Supply

Market Cap: NT$2.1b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.9b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Cenra

Market Cap: NT$5.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

3D Global Biotech

Market Cap: NT$3.8b

Develops medical materials for human body reconstruction in China.